Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

NCT01142427 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01142427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01142427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
August 9, 2010
Completion date
September 30, 2023
Enrollment
17,463 (actual)
Sites
244

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia